secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cosmos Health Inc. (COSM)
CIK:        0001474167
Form:       8-K
Filed at:   2023-04-18T23:59:59+00:00
Accession:  0001477932-23-002688
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cosmos Health FY2022 revenue down 10.5% to $50.3M; positive adjusted EBITDA, debt reduced 76%
--------------------------------------------------------------------------------

- Revenue $50.3M vs $56.2M; constant-currency increase of $0.4M; net loss $13.8M vs $7.96M.
- Adjusted EBITDA positive $0.5M (down from $3.3M in FY2021); going-concern doubt resolved.
- Cash & securities $21M (vs $0.3M); long-term debt cut to $5.1M from $21.4M.
- Raised $56.5M via equity/warrants; acquiring Cana Laboratories and ZipDoctor.
- R&D partnership with Cloudpharm for obesity/diabetes; launched Mediterranation supplements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1474167/000147793223002688/0001477932-23-002688-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1474167/000147793223002688/cosm_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-23-002688

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer